Lyra Therapeutics, Inc. - LYRA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | Principal Financial Officer | D | D | 667.0 | 0.0 | 0.0 | 517,880.0 | View | |
| Apr 03, 2026 | Principal Executive Officer | D | D | 2,000.0 | 0.0 | 0.0 | 1,094,733.0 | View | |
| Jan 08, 2026 | President & CEO | S | D | 1,702.0 | 3.364 | 5,725.53 | 1,096,733.0 | View | |
| Jan 08, 2026 | Chief Financial Officer | S | D | 769.0 | 3.364 | 2,586.92 | 518,547.0 | View | |
| Nov 13, 2025 | — | S | D | 3,213.0 | 3.9001 | 12,531.02 | 14,026.0 | View | |
| Nov 13, 2025 | — | S | D | 28,597.0 | 3.9001 | 111,531.16 | 124,859.0 | View | |
| Nov 13, 2025 | — | S | D | 883.0 | 4.0594 | 3,584.45 | 17,239.0 | View | |
| Nov 13, 2025 | — | S | D | 7,862.0 | 4.0594 | 31,915.0 | 153,456.0 | View | |
| Nov 13, 2025 | — | S | D | 537.0 | 4.3146 | 2,316.94 | 18,122.0 | View | |
| Nov 13, 2025 | — | S | D | 4,783.0 | 4.3146 | 20,636.73 | 161,318.0 | View | |
| Nov 10, 2025 | — | S | D | 1,869.0 | 4.5398 | 8,484.89 | 18,659.0 | View | |
| Nov 10, 2025 | — | S | D | 16,633.0 | 4.5398 | 75,510.49 | 166,101.0 | View | |
| Nov 10, 2025 | — | S | D | 1,993.0 | 4.7467 | 9,460.17 | 20,528.0 | View | |
| Nov 10, 2025 | — | S | D | 17,746.0 | 4.7467 | 84,234.94 | 182,734.0 | View | |
| Nov 10, 2025 | — | S | D | 3,247.0 | 5.1799 | 16,819.14 | 22,521.0 | View | |
| Nov 10, 2025 | — | S | D | 28,902.0 | 5.1799 | 149,709.47 | 200,480.0 | View |